This panel at the Community Oncology Alliance conference discussed the impact of PBM response to the end of direct and indirect remuneration (DIR) fees, which has been dramatic cuts to cancer drug reimbursement.
There is bipartisan support in the Congress for the Community Oncology Alliance's (COA) key agenda items, with hope that some will pass by year’s end.
Reps. Vern Buchanan (R-Fla.), Adrian Smith (R-Neb.) and Jason Smith (R-Mo.) have all thrown their hats in the ring to replace retiring Rep. Kevin Brady (R-Texas).